GB Patent

GB2265845B — A nebuliser and nebuliser control system

Assigned to BASETRADE Ltd · Expires 1996-05-01 · 30y expired

What this patent protects

PCT No. PCT/GB92/02098 Sec. 371 Date May 10, 1994 Sec. 102(e) Date May 10, 1994 PCT Filed Nov. 12, 1992 PCT Pub. No. WO93/09881 PCT Pub. Date May 27, 1993A nebulizer for use in administering a medicament to a patient undergoing treatment for example, comprises an ultrasonic piezo…

USPTO Abstract

PCT No. PCT/GB92/02098 Sec. 371 Date May 10, 1994 Sec. 102(e) Date May 10, 1994 PCT Filed Nov. 12, 1992 PCT Pub. No. WO93/09881 PCT Pub. Date May 27, 1993A nebulizer for use in administering a medicament to a patient undergoing treatment for example, comprises an ultrasonic piezo-electric transducer (60) and a transducer drive system (D) which is caused to drive said transducer at or near its anti-resonant frequency. There is also provided means to optimize nebulized fluid particle size and transfer to the patients lungs for example, by operating at an anti-resonant frequency in the range of 1.36 to 1.56 MHz and having a single outlet baffle and relatively short outlet tube (24) arrangement.

Drugs covered by this patent

Patent Metadata

Patent number
GB2265845B
Jurisdiction
GB
Classification
Expires
1996-05-01
Drug substance claim
No
Drug product claim
No
Assignee
BASETRADE Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.